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Centrosomes are the major microtubule nucleating center in the cell; they also contribute to spindle pole organization and play a role in cell
cycle progression as well as completing cytokinesis. Here we describe the molecular characterization of a novel human gene, CEP55, located in
10q23.33 that is expressed in multiple tissues and various cancer cell lines. Sequence analysis of the cDNA predicted a protein of 464 amino acids
with several putative coiled-coil domains that are responsible for protein–protein interactions. Indeed, we found homodimerization of CEP55 by
coimmunoprecipitation. Subcellular localization analysis revealed that endogenous CEP55 as well as an EGFP–CEP55 fusion protein is present at
the centrosome throughout mitosis, whereas it also appears at the cleavage furrow in late anaphase and in the midbody in cytokinesis. Neither
nocodazole nor taxol interfered with centrosome association of endogenous CEP55, suggesting that it directly interacts with centrosome
components rather than with microtubules. In microtubule regrowth assays, overexpression of CEP55 did not enhance or inhibit microtubule
nucleation. Together, these data suggest a possible involvement of CEP55 in centrosome-dependent cellular functions, such as centrosome
duplication and/or cell cycle progression, or in the regulation of cytokinesis.
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The centrosome has been regarded as the special organ of
cell division since its discovery in 1875. In most vertebrate
cells, centrosomes are composed of two main substructures, the
centrioles and the pericentriolar material (PCM) [1]. Centrioles
are located in the centrosome core and comprise a pair of barrel-
shaped arrays, each composed of nine sets of triplet micro-
tubules that are arranged as a pinwheel. Centrioles can be
distinguished by the presence or absence of additional
appendages and are described as mother and daughter centriole.
The pericentriolar material surrounds both centrioles and is the☆ Sequence data from this article have been deposited with the EMBL/
GenBank Data Libraries under Accession No. AY788918 (CEP55).
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doi:10.1016/j.ygeno.2005.11.006main site of microtubule nucleation. Although a particular
molecular organization has not yet been described for the PCM,
it is a dynamic matrix of fibers and protein aggregates [1].
Different classes of centrosomal proteins are known. The first
class comprises proteins that are responsible for maintaining the
structure of the centrosome and they serve as a scaffold for the
assembly of other proteins. Proteins that function in microtubule
nucleation belong to the second group. So-called anchoring
elements, constituting the third group, form the interface
between microtubule nucleator proteins and regulatory mole-
cules. These latter proteins represent the fourth class, including
kinases, phosphatases, and signaling molecules [2]. The
majority of proteins associated with the centrosome are
structural proteins that are enriched in coiled-coil domains as
their predominant structural feature [3,4]. Coiled-coil domains
are the most commonly known oligomerization motifs in
proteins and comprise two to five right-handed amphipathic α-
helices that coil around one another to form a left-handed
supercoil [5]. In general, two groups of coiled-coil proteins can
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dimerization domains and preferentially form homo- or
heterodimers and, thus, mediate specific protein–protein
interactions [6]. Long coiled-coil domains, which encompass
several hundred amino acids, usually form “rod-like” tertiary
structures. These latter proteins are involved in diverse cellular
functions [6].
The centrosome needs to be duplicated once every cell
cycle. In a G1-phase cell, a single centrosome that is
duplicated during the S phase of the cell cycle is present. At
the G2–M transition, centrosome maturation occurs. During
mitosis, centrosomes separate from each other and form the
two spindle poles. However, recent data suggest that centro-
somes are not essential for spindle assembly in mammalian
cells [7,8], although when present, they have a dominant role
in the formation of the spindle poles [9]. Finally, in
cytokinesis, each daughter cell inherits one centrosome.
Remarkably, centrosomal abnormalities are frequently found
in many common cancers [10–12].
The centrosome was found to be required for cell cycle
progression through G1–S phase and plays a role in regulating
exit from cytokinesis [7,8,13]. These data indicate a direct link
between the centrosome and checkpoint control mechanisms by
either activating final steps of cytokinesis or releasing the cells
from a checkpoint that monitors the completion of mitosis
[14,15].
Here we describe the characterization of a novel human
gene, CEP55 (centrosomal protein, 55 kDA), located in
10q23.33 that encodes a protein capable of homodimerization.
During mitosis, subcellular localization of the endogenous
protein showed that CEP55 is associated with the centrosome in
all stages of mitosis. In anaphase, CEP55 also appears in the
midzone and during cytokinesis it concentrates in the midbody.
Remarkably, CEP55 was found to be located in the 10q24
breakpoint region of an X;10 translocation in a patient with
multiple clinical signs and symptoms.
Results
cDNA sequence and expression pattern of CEP55
Molecular characterization of an X;10 translocation in a
patient with a complex phenotype [16] revealed 26 PAC
clones overlapping the breakpoint on 10q24 by fluorescence
in situ hybridization (data not shown). The identification of
such a large number of breakpoint-spanning clones containing
no regions in common suggested the presence of a complex
rearrangement in the patient, i.e., a duplication in addition to
the translocation. To characterize novel genes located in
10q24, we performed exon-trapping experiments with one
overlapping PAC clone, C07950, and identified three putative
exons showing sequence identity to five EST clones, 305497,
242048, 199614, 504308, and 930287. We sequenced the
EST inserts and assembled a cDNA sequence that contained a
putative open reading frame (ORF), but no ATG start codon.
BLASTN analysis against genomic sequences revealed that
the gene is present on BAC clone RP11-30E16 (GenBankAccession No. AL356214). This genomic sequence was used
for RUMMAGE analysis that led to the prediction of further
5′ cDNA sequence harboring an ATG start codon. Subse-
quently, we carried out RT-PCR analysis with a forward
primer located in the predicted cDNA sequence and a reverse
primer in the assembled cDNA sequence and obtained an
amplicon that was cloned and sequenced. In total, we
generated a cDNA sequence of 2634 bp containing a possible
start codon and an ORF of 1395 bp that encodes a putative
protein of 464 amino acids. We found a homologous human
cDNA sequence in the database with GenBank Accession No.
AK001402, named C10orf3. In the 2634-bp cDNA sequence,
no stop codon upstream of the putative ATG codon is present,
suggesting that the ORF is still not complete and extends in
the 5′ direction. BLASTP analysis of the amino acid
sequences of human and mouse C10orf3 revealed that the
human open reading frame shows 75% identity and 86%
similarity to the mouse protein (data not shown). The
homology between both amino acid sequences starts with
the first methionine. Moreover, a stop codon is located 15 bp
upstream of the start codon in the murine cDNA sequence,
suggesting that the identified ATG triplet in the human cDNA
represents the proper start codon. BLASTN analysis using the
human cDNA sequence against genomic sequences showed
that the gene is composed of nine exons spanning a genomic
region of 32,458 bp. The start codon lies in exon 2 and the
stop codon is located in exon 9. Further characterization of
the protein encoded by this gene (see below) resulted in
renaming it CEP55, centrosomal protein, 55 kDA.
We used various computer analysis software programs,
including PROSITE, SMART, PFAM, FALTA, and PSORT, to
analyze the deduced amino acid sequence of the human
CEP55 ORF. No significant homologies to other proteins or
domains were found. However, a database search at the NCBI
BLAST Network Service using the Conserved Domain (CD)
database revealed partial homology to chromosome segrega-
tion ATPases that play a role in cell division and chromosome
partitioning.
We analyzed expression of CEP55 by probing a multiple
adult human tissue Northern blot. A transcript of ∼2800 nt
was detected that corresponds well to the cDNA sequence of
2634 bp, suggesting that we obtained the full-length cDNA.
We observed strong expression of CEP55 in thymus and weak
expression in colon, small intestine, and placenta (Fig. 1A).
To confirm the expression pattern, we probed a commercially
available RNA array from multiple human tissues and
observed a strong signal in testis and intermediate signals in
adult and fetal thymus as well as in various cancer cell lines.
Low-level expression was found in different parts of the
digestive tract, bone marrow, lymph nodes, placenta, fetal
heart, and fetal spleen (Fig. 1B). In summary, CEP55
expression is clearly detectable in highly proliferating tissues,
whereas in tissues with low proliferative activity, such as
brain, almost no signals could be observed. However,
expression of CEP55 was present in all tissues of the
multiple-tissue RNA array after a long exposition time (data
not shown).
Fig. 1. The CEP55 transcript is highly expressed in testis, thymus, bone marrow, and various cancer cell lines. (A) Hybridization of part of the coding region of CEP55
to an adult human multiple tissue Northern blot containing total RNA. A single transcript of ∼2800 nt was detectable in colon, thymus, small intestine, and placenta,
with strongest expression in thymus. The same blot was reprobed with a β-actin probe. (B) Hybridization of the same probe to a commercially available RNA (MTE)
array. Hybridization signals are shown that are represented by dots of differing shades of gray.
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and shows homophilic binding
To analyze possible secondary structures of CEP55, we used
different programs predicting coiled-coil regions (COILS, PAIR-
COIL, and MULTICOIL). At least six putative coiled-coil motifs
are scattered along the entire amino acid sequence of CEP55 (Fig.
2A), offering CEP55 the potential to homo- or heterodimerize andFig. 2. CEP55 contains numerous coiled-coil motifs and shows homophilic binding. (A
PAIRCOIL program (http://paircoil.lcs.mit.edu/cgi-bin/paircoil). (B) Identification o
cells were transfected with both FLAG- and HA-tagged constructs of CEP55. HA-tag
Expression of FLAG-tagged proteins in lysates (indicated by an arrowhead in the boform higher-order oligomers. We coexpressed full-length FLAG-
and HA-tagged CEP55 in CHO-K1 cells and performed
coimmunoprecipitation experiments with anti-FLAG antibody.
As shown in Fig. 2B, HA-tagged CEP55 was detected in
precipitates of cell lysates transfected with FLAG-CEP55 cDNA
(Fig. 2B, top, lane 2), but not in those obtained after transfection
with empty FLAG-vector (Fig. 2B, top, lane 1). These data suggest
that CEP55 is able to form homodimers in CHO-K1 cells in vivo.) Schematic representation of the coiled-coil prediction of CEP55 obtained by the
f CEP55 homophilic binding by coimmunoprecipitation experiments. CHO-K1
ged CEP55 was detected after coimmunoprecipitation with anti-FLAG antibody.
ttom, lane 4) and precipitates (bottom, lane 2) was confirmed by immunoblot.
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CEP55 during mitosis
The specificity of polyclonal antibodies raised against the
first 250 amino acids of CEP55 was demonstrated by Western
blot analysis of cell lysates prepared from CHO-K1 cells
ectopically expressing HA- or EGFP-tagged CEP55 protein
(Fig. 3). It is of note that endogenous CEP55 protein was not
detected (Fig. 3, left lane). This suggests that the CEP55 protein
expression level is low, which is in line with the expression data
obtained by Northern blot analysis (Fig. 1).
To obtain first insights into the biological function of
CEP55, we determined the subcellular localization of the
endogenous protein. Therefore, CHO-K1 cells were coimmu-
nostained with antibodies against CEP55 and α-tubulin and
analyzed by fluorescence microscopy. In interphase cells,
CEP55 signals could be detected as one or two closely spaced
dots, which are usually located close to the nuclear envelope
(Figs. 4A–4C, and data not shown). These intense dots are
present in the area of the microtubule organization center
(MTOC), suggesting that they represent centrosomes. Addi-
tionally, numerous small vesicular structures were detected in
the cytoplasm (indicated by arrowheads in Fig. 4A). In
prophase and metaphase, prominent CEP55 signals were
detectable at the spindle poles (Figs. 4D–4I). Remarkably,
staining of CEP55 was found at the cleavage furrow as well
as at the spindle poles during late anaphase (Figs. 4J–4L). In
addition, we observed an elevated green fluorescence,
indicative of the presence of CEP55, in the cytoplasm during
this stage of mitosis (Figs. 4J and 4L). Finally, a prominent
staining was detected in the central region of the cytoplasmic
bridge, the midbody, although a weak staining still remained
at the centrosomes in telophase (Figs. 4M–4O). Together
these results show that CEP55 is associated with the
centrosome throughout mitosis and concentrates in theFig. 3. Specific detection of ectopically expressed CEP55 by anti-CEP55
antibodies. CHO-K1 cells, either nontransfected or transfected with HA- or
EGFP-tagged CEP55, were lysed, protein lysates were separated by SDS–
PAGE, and immunoblot was performed with anti-CEP55 antibodies. Expression
of HA- or EGFP-tagged CEP55 protein was specifically detected by the anti-
CEP55 antibodies (top, middle and right lanes), whereas the endogenous CEP55
protein could not be detected (top, left lane). As a control, the expression of actin
was confirmed in all cell lysates (bottom).midbody in cytokinesis. It is important to note that we
observed no such staining with the pre-immune serum (data
not shown).
Next, we wanted to analyze the cellular distribution of
CEP55 in more detail and generated CHO-K1 cells stably
expressing an N-terminal tagged EGFP–CEP55 fusion
protein. We synchronized the cells to study the cellular
distribution of the fusion protein compared to the endogenous
protein. Indeed, the EGFP–CEP55 protein showed a very
similar subcellular localization as the endogenous CEP55
during mitosis (Fig. 5). Staining of cells with anti-γ-tubulin
antibodies revealed colocalization of EGFP–CEP55 with γ-
tubulin in prophase, indicating that CEP55 shows a
centrosomal localization (Fig. 5C). Together, the cellular
distribution of EGFP–CEP55 that matches that of the
endogenous protein makes it a suitable tool to analyze the
dynamics of CEP55 redistribution during mitosis.
EGFP–CEP55 resides at the centrosome in all stages of
mitosis but also appears in the spindle midzone during
anaphase and in the midbody in postmitotic stages
We performed live-cell videomicroscopy on synchronized
CHO-K1 cells stably expressing EGFP–CEP55. In prophase,
two prominent diffuse accumulations of green fluorescence at
the centrosomes could be observed (Figs. 6A–6C, and
Supplementary Data). Some very faint vesicular structures
moving inside the cell were also detected (video available as
Supplementary Data). In metaphase, a diffuse cytoplasmic
labeling was apparent in addition to the signals at the
centrosomes (Figs. 6D and 6E). With the beginning of
anaphase, a weak signal at the central region of the spindle
became visible (Fig. 6F). Interestingly, this staining was
remarkably granular/vesicular. However, no transport of
vesicular structures to the central region could be detected.
The fluorescence signal at the central region increased until
telophase onset (Fig. 6G). In parallel, a slight reduction of the
cytoplasmic EGFP–CEP55-signal could be observed. When the
contractile ring started to cord up, the signal at the central region
became more and more concentrated (Figs. 6H–6L), resulting
in a brightly fluorescent midbody during cytokinesis (Fig. 6M).
The signal at the centrosomes remained mainly unchanged
during the whole process. Thus, it appears unlikely that CEP55
was redistributed from the centrosome to the spindle midzone.
Instead, our data suggest that CEP55 might be recruited from a
cytoplasmic pool to the spindle midzone.
Centrosome association of CEP55 is independent of
microtubules and CEP55 overexpression does not seem
to have any effect on microtubule nucleation
CHO-K1 cells were cultivated in the presence of nocoda-
zole and taxol, respectively. Nocodazole results in depolymer-
ization of the cytoplasmic microtubule network, whereas taxol
treatment has a stabilizing effect on microtubules, leading to
long microtubule bundles and loss of centrosome-nucleated
microtubules [17]. If CEP55 binds to microtubules, its
Fig. 4. Endogenous CEP55 is present at the centrosome in all stages of mitosis, appears at the cleavage furrow in late anaphase, and concentrates at the center of the
midbody in cytokinesis. CHO-K1 cells were costained with anti-CEP55 and anti-α-tubulin antibodies. In interphase, CEP55 was present in one dot in the cell (A) and
is located in the MTOC area (C). Light blue arrowheads point to the localization of CEP55 in small vesicular structures in the cell (A). In prophase and metaphase cells,
CEP55 appeared at the spindle poles (D, F, G, and I). CEP55 was present at the cleavage furrow, at the spindle poles, and in the cytoplasm in late anaphase (J and L),
and concentrated in the midbody during cytokinesis (M and O). Nonetheless, CEP55 is still faintly visible at the centrosomes (yellow arrows in M). The scale bars
represent 10 μm.
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subcellular distribution of α- or γ-tubulin. In CHO-K1 cells
incubated with taxol and stained with anti-α- and anti-γ-
tubulin antibodies as well as anti-CEP55 antibodies, the
microtubules appeared as dense bundles that were detached
from the centrosomes in the majority of cells (Fig. 7D). In
these cells, CEP55 staining was still restricted to punctated
signals (Fig. 7E) and colocalization of CEP55 with γ-tubulin
was observed in the presence of taxol-induced asters (Fig. 7F).
In cells treated with nocodazole and costained with the anti-α-
and anti-γ-tubulin antibodies, microtubules were completely
absent (Fig. 7G). However, endogenous CEP55 was stillpresent at the centrosome (Fig. 7H) as shown by colocalization
with γ-tubulin (Fig. 7I).
To analyze whether overexpression of CEP55 has any effect
on microtubule nucleation, we performed a microtubule regrowth
assay with nontransfected cells and cells that transiently
expressed EGFP–CEP55. After microtubules were depolymer-
ized, microtubule regrowth was induced and cells were fixed,
costained with anti- γ- and anti-α-tubulin antibodies, and
subsequently analyzed by immunofluorescence. EGFP–CEP55-
expressing cells (Fig. 8D) showed one center of microtubule
nucleation with many long and thin microtubules that arose from
the centrosome (Fig. 8F). Under these conditions, no additional
Fig. 5. EGFP–CEP55 shows a subcellular localization comparable to the endogenous protein. CHO-K1 cells stably expressing EGFP–CEP55 were incubated with
thymidine. Subsequently, cells were washed and incubated at 37°C for 5 h. A second incubation step for 5 h with nocodazole was performed to arrest the cells at
prometaphase. To obtain cells during different mitotic stages, nocodazole was washed out and preextraction followed by methanol fixation was performed at multiple
time points. Cells in prophase were stained with an anti-γ-tubulin antibody (B), whereas cells in all other mitotic stages were stained with an anti-α-tubulin antibody (E,
H, K, N). DAPI was used to visualize DNA (C, F, I, L, O). Arrowheads point to the localization of the EGFP–CEP55 fusion protein. In prophase, EGFP–CEP55 was
present in two dots in the cell (A) and colocalized with γ-tubulin at the centrosomes (C). In metaphase cells, EGFP–CEP55 appeared at the centrosome (D, F). During
anaphase A, EGFP–CEP55 remained at the centrosome; however, it also started to accumulate in the spindle midzone (G, I). This localization became more apparent in
anaphase B (J, L). During cytokinesis, the EGFP–CEP55 protein was visible in the midbody (M, O). Nonetheless, a centrosomal localization was still present in
anaphase B and cytokinesis (L, O). The scale bar represents 10 μm.
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Fig. 6. Dynamics of CEP55 redistribution during mitosis. CHO-K1 cells stably expressing EGFP–CEP55 were synchronized as described in the legend to Fig. 5. After
nocodazole was washed out, cells were directly analyzed using live-cell fluorescence microscopy. Selected frames of a videosequence covering 52 min are depicted,
showing an EGFP–CEP55-positive cell passing through mitosis. Prometaphase (A–C); metaphase (D and E); anaphase (F and G); telophase (H–K); cytokinesis (L
and M). Note the fluorescence signals at the centrosomes, the increasing, granular/vesicular signal at the central region of the spindle (F–J), and the concentrated signal
at the midbody (M). The corresponding videosequence is available as supplementary material. The scale bars represent 10 μm.
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and 8C). Thus, overexpression of CEP55 neither enhances nor
perturbs the assembly of microtubules.
Discussion
During molecular characterization of an X;10 translocation
in a patient with various clinical signs and symptoms, we ended
with the finding of a putative complex rearrangement in the
10q24 breakpoint region that significantly hampered determi-Fig. 7. CEP55 remains associated with the centrosome in cells treated with either
nocodazole or taxol. CHO-K1 cells were incubated with taxol to stabilize
microtubuli and detach them from the centrosome. Cells were subsequently
preextracted and fixed with methanol, and staining of untreated (A–C) or treated
cells was performed with anti-α- and anti-γ-tubulin antibodies and anti-CEP55
antibodies. All cells were affected by the taxol treatment since microtubules
appeared as dense bundles (D). CEP55 localization was restricted to various dots
in the cell (E) and colocalization with γ-tubulin was observed (F). CHO-K1 cells
were incubated with nocodazole to depolymerize microtubuli. Costaining of
cells with anti-α- and anti-γ-tubulin antibodies as well as anti-CEP55 antibodies
showed the complete absence of microtubuli in the cell (G). A CEP55 signal is
still visible at the centrosome (H). When images were overlaid, the yellow signal
generated indicated colocalization of CEP55 with γ-tubulin (I). The scale bars
represent 10 μm.nation of the sequences flanking the X chromosomal and the
chromosome 10 breakpoints. However, we analyzed the X
chromosome breakpoint in detail and identified the FAM9 gene
family present in Xp22.3 [16].
In an attempt to find novel genes located in the 10q24
breakpoint region, we characterized a 2634-bp cDNA that is
expressed in thymus, colon, small intestine, placenta, different
parts of the digestive tract, bone marrow, lymph nodes, fetal
heart, and fetal spleen as well as in various cancer cell lines.
This gene was designated CEP55 (centrosomal protein, 55
kDA) and spans nine exons on genomic DNA. We used
numerous computer programs for the identification of putative
protein motifs and observed multiple short coiled-coil domains
spanning almost continuously the length of the amino acid
sequence. These coiled-coil motifs are frequently found to be
responsible for homo- and heterodimerization and, thus,
mediate protein–protein interactions [6]. Indeed, we showed
homodimerization of CEP55, suggesting that higher oligomer
structures can be formed. Proteins containing coiled-coil motifs
are highly enriched in the pericentriolar matrix surroundingFig. 8. Overexpression of CEP55 does not affect microtubule nucleation. For
the microtubule regrowth assay, nontransfected and transiently expressing
EGFP–CEP55 cells were treated with nocodazole, washed, and placed into
fresh medium. Cells were costained with anti-α- and anti-γ-tubulin antibodies
(A and D). Only one center of organized microtubules, the centrosome, is
visible in nontransfected (A) and EGFP–CEP55-transfected cells (D) (yellow
arrows). Colocalization of EGFP–CEP55 with γ-tubulin at the centrosome is
shown by the yellow pseudo-color (F). The scale bars represent 10 μm.
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that are required for, e.g., microtubule nucleation [14].
Subcellular localization studies of endogenous CEP55 as
well as CEP55 fused to EGFP showed that it localized to the
centrosome during all stages of mitosis as well as in paired cells
that were still connected by postmitotic bridges (early G1
phase). These data suggest that CEP55 might be associated with
the centrosome throughout the cell cycle, although we cannot
yet exclude the possibility that CEP55 translocates to other sites
within the cell during late G1 and/or S phase. The centrosomal
association of CEP55 was found to be independent of
microtubules, suggesting that CEP55 is a core component of
the centrosome that might be recruited to the pericentriolar
matrix by other yet to be defined proteins. Microtubule-
independent centrosome association has been described for
various proteins, such as CTCF [18], Nek2 [19], Cep135 [20],
and γ-tubulin [21]. Moreover, the ectopic expression of CEP55
has no effect on microtubule regrowth, suggesting that CEP55 is
most likely not involved in microtubule-dependent functions in
the cell.
During anaphase, CEP55 is present at the centrosome and
also appears in the spindle midzone. Finally, it becomes
concentrated in the center of the midbody in cytokinesis. This
specific cellular localization of CEP55, an α-helical protein,
during mitosis raises the question of a possible involvement in
centrosome function and/or regulation of cytokinesis as shown
for other proteins. Recently, a novel coiled-coil protein,
centriolin, of the maternal centriole that is present at the
centrosome through all stages of the cell cycle has been
described. However, during cytokinesis, centriolin initially
appeared within the intercellular bridge and subsequently
became concentrated in the midbody. Silencing of centriolin
induces cytokinesis failure, indicating an important role for
centriolin in the late stages of cytokinesis [22]. The protein
tyrosine phosphatase PTP-BL localizes to the centrosomes in
inter- and metaphase, is present in the midzone in anaphase, and
accumulates in the midbody in cytokinesis. PTP-BL was also
shown to be implicated in the regulation of cytokinesis [23].
Similarly, the presence of CEP55 in the spindle midzone and the
midbody in addition to its centrosomal localization suggested a
possible role of CEP55 in cytokinesis regulation.
A number of proteins that are not associated with the
centrosome localize to the midzone of the mitotic spindle and
the midbody, such as PRC1 and the citron-kinase [24,25].
Remarkably, PRC1 contains multiple coiled-coil motifs in its N-
terminal region. PRC1 is a microtubule-associated protein that
stabilizes the microtubule bundle of the midzone and is required
to maintain the spindle midzone [25]. Similarly, the Rab6-
binding kinesin protein Rab6-KIFL and the large GTPase
dynamin accumulate in the midzone in anaphase and in the
midbody in cytokinesis. For both proteins an important function
in completion of cytokinesis has been suggested [26,27]. It is of
interest to note that various midbody proteins have been shown
to function in cell cycle regulation as well as in asymmetric cell
division and chromosome segregation [28].
The localization of CEP55 in a chromosomal region that is
present in three copies in the genome of the t(X;10) patient led usto hypothesize that higher CEP55 mRNA and protein levels
might have contributed to the patient’s phenotype. In this
context, it is worth mentioning that mutations in three genes,
namely, BBS4, SPG4, and OFD1, encoding proteins associated
with the centrosome are known to be responsible for different
human inherited disorders [29–31]. Thus, the recent discovery
of defects in centrosome function or microtubule organization in
human inherited diseases demonstrates that centrosome organi-
zation, centrosome-mediated microtubule events, and the
possible involvement of the centrosome in the activation of
checkpoints during cell cycle and cytokinesis [14] are important
for proper function of various cell types and tissues [32].
Moreover, centrosomal aberrations have been noted to be
involved in many common cancers, such as breast, colon, lung,
and prostate [12]. Further studies are required to elucidate the
precise cellular function of CEP55; however, given its
centrosomal localization in all stages of mitosis and its
presence in the spindle midzone and midbody, we assume
that it might be implicated (directly or indirectly) in regulatory
functions of the centrosome during the cell cycle and/or
regulation of cytokinesis.
Materials and methods
DNA isolation of PAC clones and exon trapping
PAC clone RPCIP704C07950Q3 (C07950) was provided by the RZPD
Deutsches Ressourcenzentrum für Genomforschung GmbH, Berlin, Germany.
PAC DNA was prepared using a plasmid midiprep kit (Qiagen). PAC clone
C07950 was digested with BamHI, BglII, PstI, and SacI, respectively, and the
resulting pools of fragments were cloned into pSPL3. Exon trapping was
performed by the Exon Trapping System (Life Technologies/Invitrogen)
following the manufacturer’s instructions.
EST clones
EST clones 305497, 242048, 199614, 504308, and 930287 (GenBank
Accession Nos. W39078, H94225, R96554, AA131908, and AA502823) were
provided by the RZPD Deutsches Ressourcenzentrum für Genomforschung
GmbH, Berlin, Germany. DNA inserts were sequenced using T7 and T3 primers
and by primer walking (primer sequences are available from the authors on
request).
RT-PCR
For RT-PCR, human testis poly(A) mRNA was used (BD Biosciences
Clontech). First-strand cDNAs were synthesized using 200 ng of RNA,
SUPERSCRIPT II RNase H− Reverse Transcriptase (Invitrogen), and random
hexamers (Invitrogen). Of each first-strand reaction, 2 μl was taken as template
in PCRs using cDNA Advantage Polymerase (BD Biosciences Clontech)
(primer sequences are available from the authors on request). For amplification
of the coding region of CEP55, we used 2 μl of each first-strand reaction in
PCRs using cDNA Advantage Polymerase (BD Biosciences Clontech) and
primers MultiRT4 (5′-GACCGTTGTCTCTTCGATCGCTTC-3′) and Multig2
(5′-GTATTCCACATGGACAAGCAGATC-3′). Amplicons were cloned and
sequenced. The resulting clone pMG42 was used as starting material for the
generation of EGFP fusion proteins by the GATEWAY system (see below).
Northern blot analysis
A 580-bp PCR product containing part of the CEP55 cDNAwas amplified
with primers O02F (5′-GCAGTGGCTCGTGTATGATCAGC-3′) and O02R
(5′-GATGCTGCACATGTTGACGGTCG-3′) and radiolabeled by random
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dCTP (Amersham Biosciences). A commercial human multiple tissue blot
(MTN, BD Biosciences Clontech) was hybridized according to the manufac-
turer’s instructions, washed at high stringency, and exposed to X-ray film.
Positive signals were detected by autoradiography. To control for RNA integrity
and loading amount, the blot was rehybridized with α-32P-labeled β-actin probe
as described in the protocol provided. A commercial human multiple tissue
expression array (MTE, BD Biosciences Clontech) was hybridized according to
the manufacturer’s instructions, washed at high stringency, and exposed to X-ray
film.
Antibody production
A cDNA fragment corresponding to amino acids 2–250 of CEP55 was
subcloned in-frame into pGEX-3T plasmid (Amersham Pharmacia Biotech).
The glutathione S-transferase (GST)–CEP55 fusion protein was expressed in
Escherichia coli BL21 and purified with glutathione–agarose beads by using the
Bulk and RediPack GST purification modules (Amersham Pharmacia Biotech)
according to the manufacturer’s instructions. Anti-CEP55 antibodies were raised
by immunizing rabbits with the GST–CEP55 protein (aa 2–250) (Biogenes).
The IgG fraction of this antiserum was purified (named AK40-5307)
(Biogenes).
Generation of an N-terminal-tagged enhanced green fluorescent
protein CEP55 fusion construct
For PCR amplification of the coding region of CEP55, we used pMG42 as a
template and primers MultiC3F (5′-GGGGACAAGTTTGTACAAAAAAG-
CAGGCTTGTCTTCCAGAAGTACCAAAG-3′) and MultiC3R (5′-
GGGGACCACTTTGTACAAGAAAGCTGGGTGTTACTACTTTGAACAG-
TATTCCAC-3′) for constructing an N-terminal EGFP fusion construct.
Amplification was performed by using cDNA Advantage polymerase (BD
Biosciences Clontech) and the PCR product was purified according to the
instructions of the GATEWAY system. Cloning of the PCR product into “donor
vector” pDONR207 (Invitrogen) via BP reaction yielded clone pMG47. Verified
clones were used for cloning the coding region of CEP55 into pEGFP-C3-
cassetteAvia LR reaction according to the manufacturer’s protocol. GATEWAY-
compatible plasmid pEGFP-C3-cassetteAwas generated as previously described
for pEGFP-N3-cassetteA [16].
Generation of the GATEWAY-compatible plasmid pMT2SM-HA-DEST
and N-terminal HA- and FLAG-tagged CEP55 constructs
Plasmid pMT2SM-HAwas digested with SmaI and EcoRI and purified and
subsequent filling of recessed 3′ termini was performed by the Klenow fragment
(Invitrogen). After alkaline phosphatase treatment and a second purification
step, the plasmid was ligated to the GATEWAY Reading Frame Cassette C
(RfC) of the GATEWAY Vector Conversion system (Invitrogen) according to
the manufacturer’s instructions. The obtained GATEWAY-compatible “destina-
tion vector,” pMT2SM-HA-DEST, was propagated in E. coliDB3.1 (Invitrogen)
to compensate for the expression of the ccdB gene. The plasmid was sequenced
for integrity and correct orientation of the cassette. pMG47 was used for cloning
the coding region of CEP55 into vectors pMT2SM-HA-DEST and pFLAG-
CMV-4-cassetteA [33] via LR reaction according to the manufacturer’s
protocol. All described constructs were sequenced for integrity and large and
pure amounts of plasmid DNAwere prepared by using a plasmid midi or maxi
kit (Qiagen).
Cell culture and synchronization
CHO-K1 cells were maintained in F12-Ham’s Nutrient Mixture (Invitrogen)
supplemented with 10% FCS, 1% L-glutamine, and penicillin–streptomycin
(Invitrogen). To obtain cells synchronized at M phase, CHO-K1 cells were
grown on coverslips (analysis of fixed cells) or on LabTek chambered 4-well
coverglasses (Nalge Nunc) (for videomicroscopic analysis) to 40–70%
confluency and treated with 5 mM thymidine (Sigma) for 17 h to arrest the
cell cycle at the S and G1–S stages. Subsequently, cells were washed andincubated at 37°C for 5 h. Cells were exposed to 0.05 μg/ml nocodazole (Sigma)
for an additional 5 h to arrest cells at prometaphase. After the drug was carefully
washed out from the culture, cells were incubated further in fresh medium at
37°C. For cells grown on coverslips, preextraction followed by methanol
fixation was performed at different time points within a 0- to 80-min period that
allowed us to observe cells at different stages of mitotic progression. Cells
grown on LabTek chambers were directly analyzed by time-lapsed fluorescence
videomicroscopy.
Drug treatments and microtubule regrowth assay
CHO-K1 cells were treated with either 6 μg/ml nocodazole (Sigma) or 5 μM
taxol (Sigma) for 4 h and then processed immediately for immunofluorescence
analysis. For the microtubule regrowth assay, microtubules were depolymerized
by a 4-h treatment with 6 μg/ml nocodazole and then regrowth was induced by
washing the cells three times with PBS and placing them into fresh medium
(without nocodazole) at 37°C for 2 min before fixation (with 4% paraformal-
dehyde) and immunofluorescence analysis.
Transfection
Sterile coverslips were placed in 12- and 24-well dishes and seeded with
1.2 × 105 and 2 × 104 CHO-K1 cells, respectively. Twenty-four hours later,
cells were transiently transfected with an EGFP–CEP55 or HA–CEP55
fusion construct using Lipofectamine 2000 reagent (Invitrogen) according to
the manufacturer’s protocol. Twelve to fifteen hours after transfection, the
well coverslips were rinsed with PBS and mounted with nail enamel. To
obtain CHO-K1 cells stably expressing N-terminal fused EGFP to CEP55, we
transiently transfected cells, split them 1/10, and incubated the cells for a
further 24 h before adding geneticin (Invitrogen) to a concentration of 1 mg/
ml. After 1 week, surviving cells were pooled and grown in the presence of
geneticin.
Immunoblotting
Protein lysates were separated by 10% SDS–PAGE and transferred to a
nitrocellulose membrane (Amersham Pharmacia Biotech) via the semidry
blotting method. The membrane was blocked with 4% low-fat milk in Tris-
buffered saline and then incubated with the appropriate antibody solution.
Detection of bound antibodies was carried out using a ECL detection kit
(Amersham Pharmacia Biotech). Anti-CEP55 antibody was used at 1:800
dilution, HRP-conjugated anti-mouse Ig (Sigma) and HRP-conjugated anti-
rabbit Ig (Sigma) were used at 1:12,000 dilution, and anti-actin antibodies
(Sigma) at 1:500 dilution.
Immunofluorescence
Nontransfected cells or cells 12 to 14 h after transient transfection, which
were grown on coverslips, were rinsed with PBS, pre-extracted with 0.3%
Nonidet P-40 (NP-40), 1 mM MgCl2, 80 mM PIPES/KOH, pH 6.8, and 5 mM
EGTA in 1× PBS, and fixed with 4% paraformaldehyde or in cold methanol
(−20°C) for 10 min. After being washed three times with PBS for 10 min, cells
were incubated with 1% BSA, 3% goat serum, and 0.5% NP-40 in PBS for 60
min to permeabilize cells and block nonspecific antibody binding. To detect γ-
tubulin, cells were stained with monoclonal anti-γ-tubulin GTU-88 (1:500
dilution; Sigma), followed by incubation with Alexa Fluor 546 goat anti-
mouse IgG (4 μg/ml; Mobitec). To detect α-tubulin, cells were stained with
monoclonal anti-α-tubulin DM 1A (1:1000 dilution; Sigma), followed by
incubation with Alexa Fluor 546 goat anti-mouse IgG (4 μg/ml; Mobitec). For
detection of endogenous CEP55, cells were stained with polyclonal rabbit
serum AK40-5307 or PI-AK40-5307 (pre-immune) (both at 1:1000 dilution),
followed by incubation with Alexa Fluor 488 goat anti-rabbit IgG (1:1500;
Mobitec). After being washed twice with high-salt PBS (650 mM NaCl) and
three times with PBS, cells on coverslips were mounted in glycerol gelatin
containing 1% phenol (Sigma). Cells were examined with a Leica TCS-NT
confocal microscope equipped with an Apo 40 × 1.0 oil immersion objective
lens.
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High-resolution fluorescence videomicroscopy was performed with a
monochromator-based imaging system (T.I.L.L. Photonics) as described in
[34], except that a triple-band filter set DAPI/FITC/TRITC F61-020 (AHF
Analysentechnik) was used. The imaging system was equipped with a 37°C
heating control device and a 5% CO2 supply (Live Imaging Services). For time-
lapse analysis, 13 consecutive videosequences, each consisting of 100 frames
with a time distance of 264 ms, were taken. The videos were finally combined
into one videofile covering 52 min.
Coimmunoprecipitation
CHO-K1 cells were cultured in 100-mm culture dishes. A total of
1.2 × 106 CHO-K1 cells were transfected with pMT2SM-HA-CEP55 (4 μg
DNA) and pFLAG-CMV-4-CEP55 (4 μg DNA) or pFLAG-CMV-4-
cassetteA (4 μg DNA) (negative control) using Lipofectamine 2000
Reagent (Invitrogen) according to the manufacturer’s protocol. After 24
h of incubation, cells were lysed with ice-cold lysis buffer [150 mM Tris–
HCl, pH 8.0; 50 mM NaCl; 1 mM EDTA; 0.5% NP-40; 1 tablet Complete
Mini protein inhibitor cocktail/10 ml (Roche); 0.7 μg/ml Pepstatin] and the
lysates were clarified by centrifugation at 20,000g for 10 min at 4°C.
Supernatants were applied to 50 μl EZview Red anti-FLAG M2 Agarose
(Sigma) and incubated overnight at 4°C. Subsequently, the immunopreci-
pitates were washed three times with washing buffer (50 mM Tris–HCl, pH
7.5; 250 mM NaCl) and subjected together with total lysates to SDS–
PAGE and immunoblot analysis. Proteins were detected using HRP-
conjugated murine monoclonal anti-FLAG antibody (1:4000; Sigma) or
HRP-conjugated rat monoclonal anti-HA antibody clone 3F10 (1:4000;
Roche).
Database searches
Database searches were performed at the NCBI BLAST Network Service
using numerous databases and programs. Deduced protein sequences were
searched for functional domains using RRS-BLAST, PROSITE, PFAM, PSORT
II, COILS, PAIRCOIL, and MULTICOIL. For prediction of the CEP55 5′
cDNA sequence, the High-Throughput Sequence Annotation Server RUM-
MAGE was used.Note added in proof
During revision of this article, functional characterization of
CEP55 was independently described by another group (Fabbro
et al., Dev. Cell 9 (2005) 477–488).
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